Low doses of inhaled nitric oxide can decrease the risk of chronic lung disease and death by nearly one-fourth in premature infants who have respiratory distress syndrome (RDS), report researchers ...
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients ...
Infants undergoing heart surgery are connected to a heart-lung machine and given nitric oxide as an anti-inflammatory. Researchers from the Universities of Zurich and Queensland have now conducted the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Beyond Air has received FDA approval for ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In pregnant women with severe or critical COVID-19, ...
GARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on ...
The most severe clinical problem which coexist with the meconium aspiration syndrome/MAS/is persistent pulmonary hypertension/PPHN/. The aim of our study was to evaluate the efficacy of treatment of ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window LOS ANGELES -- ...
Beyond Air announced a PMA supplement application for the transport-ready LungFit PH II, enhancing nitric oxide delivery for respiratory care. Beyond Air, Inc. has announced the submission of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback